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Although the importance of the host tissue microenvironment in cancer progres-
sion and metastasis has been established, the spatiotemporal process establish-
ing a cancer metastasis-prone tissue microenvironment remains unknown. In this
study, we aim to understand the immunological character of a metastasis-prone
microenvironment in a murine 4T1 breast tumor model, by using the activation
of nuclear factor-jb (NF-jB) in cancer cells as a sensor of inflammatory status and
by monitoring its activity by bioluminescence imaging. By using a 4T1 breast can-
cer cell line stably expressing an NF-jB ⁄ Luc2 reporter gene (4T1 NF-jB cells), we
observed significantly increased bioluminescence approximately 7 days after
metastasis-prone orthotopic mammary fat-pad inoculation but not ectopic s.c.
inoculation of 4T1 NF-jB cells. Such in vivo NF-jB activation within the fat-pad
4T1 tumor was diminished in immune-deficient SCID or nude mice, or T cell-
depleted mice, suggesting the requirement of host T cell-mediated immune
responses. Given the fat-pad 4T1 tumor expressed higher inflammatory mediators
in a T cell-dependent mechanism compared to the s.c. tumor, our results imply
the importance of the surrounding tissue microenvironment for inflaming tumors
by collaborating with T cells to instigate metastatic spread of 4T1 breast cancer
cells.
M ounting evidence supports not only cancer cells them-selves, but also the surrounding microenvironment, as
important determinants for the progression of cancer.(1–3) The
mature tumor microenvironment consists of transformed cancer
cells and numerous other stromal cells including infiltrating
host immune cells.(1,2,4) Such tumor stromal cells have been
known to contribute to disease progression through either
direct cell–cell interactions or the production of a variety of
inflammatory mediators such as cytokines, chemokines,
matrix-degrading enzymes and growth factors.(4–7)
Given the link between inflammation and cancer has been
established, the accumulating evidence regarding the contribu-
tion of the inflammatory microenvironment in tumor progres-
sion, including angiogenesis and metastasis, has been
explored.(8–10) Clearly, the establishment of an inflammatory
tumor microenvironment requires host immune responses and,
furthermore, the activation of inflammatory signal cascades
within the tumor;(8,11–13) however, the exact behavior of such
inflammatory signals and their roles during in vivo tumor pro-
gression remain unclear. Furthermore, there is almost no defin-
itive evidence of any spatiotemporal requirement for the
establishment of an inflammatory microenvironment during
tumor growth and progression. While many molecular cues are
known to be involved in cellular inflammatory signals, nuclear
factor-jB (NF-jB) is certainly known as one of the critical
transcriptional factors to regulate the expression of pro-inflam-
matory genes in many diseases.(10,12,14) Importantly, there is
strong evidence that many oncogenes and molecules cause
activation of NF-jB. Furthermore, NF-jB is constitutively and
⁄or highly activated in malignant cancer cells and associated
with their proliferation, survival, and metastasis.(13,15–17) Thus,
the inflammatory signal mediated by NF-jB has been consid-
ered as a critical link between inflammation, immunity and
cancer progression.
In this study, we aim to understand the physiological process
of establishment of the metastasis-prone tumor microenviron-
ment in the light of cancer-associated inflammation, using
in vivo bioluminescence imaging. Using murine 4T1 cells sta-
bly expressing an NF-jB-mediated luciferase reporter gene,
we explored the spatiotemporal requirement for establishing
cancer-associated inflammation of 4T1 breast cancer in vivo.
After orthotopic mammary fat-pad inoculation, but not ectopic
s.c. inoculation, of 4T1 NF-jB cells, cancer-associated inflam-
mation was preferentially observed, as seen in the increased
bioluminescence from 4T1 tumors. Such cancer-associated
inflammatory response was diminished in immune-deficient
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SCID or nude mice, and further in both CD4+ and CD8+ T
cell-depleted mice. Thus, our results indicate the importance of
the surrounding tissue microenvironment to determine the
degree of cancer-associated inflammation in 4T1 breast tumors
by collaborating with T cells.
Materials and Methods
Reagents. Tumor necrosis factor-a (TNF-a) was purchased
from PeproTech (Rocky Hill, NJ, USA). pGL4.50 (luc2 ⁄CMV
⁄Hygro) vector, pGL4.32 (luc2P ⁄NF-jB-RE ⁄Hygro) vector and
D-luciferin were obtained from Promega (Madison, WI, USA).
Lipofectamine 2000 was purchased from Invitrogen (Carlsbad,
CA, USA). Hygromycin B was obtained from Nacalai Tesque
(Kyoto, Japan).
Cells. Mouse mammary carcinoma 4T1 cells (ATCC, Manas-
sas, VA, USA) were maintained in RPMI-1640 medium con-
taining 10% bovine serum (Nissui, Tokyo, Japan).
Establishment of luciferase-expressing 4T1 breast cancer cell
lines. The 4T1 cells stably expressing luciferase with a CMV-
promoter (4T1 CMV) and 4T1 cells stably expressing an NF-
jB-mediated luciferase gene (4T1 NF-jB) were established as
previously described.(18) Briefly, 4T1 cells (5 9 105 ⁄well) were
seeded in a 6-well plate and transfected with pGL4.50 vector or
pGL4.32 vector using Lipofectamine 2000. The cells were
selected with Hygromycin B (100 lg ⁄mL) and cloned by limit-
ing dilution. To evaluate the response of NF-jB in vitro, 4T1
NF-jB transfectants or 4T1 CMV control cells (1 9 105 ⁄well)
were cultured in a 96-well plate and treated with TNF-a
(100 ng ⁄mL). After 6 h of incubation, luminescence was mea-
sured with a multiplate reader (2030 ARVO X; Perkin Elmer
Life Science, Boston, MA, USA). In vitro characterization of
4T1 CMV or 4T1 NF-jB cells is shown in the Figure S1. There
was a clear positive correlation between luciferase activity and
cell number in both 4T1 CMV cells (Fig. S1a; R2 = 0.9922)
and 4T1 NF-jB cells (Fig. S1b; R2 = 0.9862) under stable cul-
ture conditions, therefore, luminescence of both 4T1 CMV cells
and 4T1 NF-jB cells represents a viable cell number in the
absence of stimulation. In vitro TNF-a treatment specifically
induced luciferase activity in 4T1 NF-jB cells but not in 4T1
CMV cells (Fig. S1c), confirming the activity of the NF-jB-
specific luciferase reporter system.
Experimental mouse model. Inbred wild-type BALB ⁄ c mice,
BALB ⁄ c-nu ⁄nu (nude) mice, and C.B-17 ⁄ lcrHsd-Prkdcscid
(SCID) mice were purchased from CLEA Japan, Inc. (Tokyo,
Japan) or Japan SLC (Tokyo, Japan). All experiments were
approved and carried out according to the guidelines of the
Animal Care and Use Committee of the Graduate School of
Pharmaceutical Sciences of the University of Tokyo (Tokyo,
Japan) and the Care and Use of Laboratory Animals of Univer-
sity of Toyama (Toyama, Japan). The 4T1 CMV cells or 4T1
NF-jB cells were inoculated s.c. or into mammary fat-pad
(i.f.p.). Mice were injected with D-luciferin (150 mg ⁄kg i.p.;
Promega) and luminescence was measured with an in vivo
imaging system (IVIS Spectrum; Caliper Life Sciences, Hopk-
inton, MA, USA) 20 min after the D-luciferin injection. For
CD4+ or CD8+ T cell depletion, mice were injected i.p. with
0.25 mg anti-CD4 antibody (clone GK 1.5) or anti-CD8 anti-
body (clone 53.6.2) on Day 2, 1, and 7 relative to the
tumor implantation. The index of relative induction of lumi-
nescence was calculated as: (Day 7 luminescence of 4T1 NF-
jB tumor ⁄Day 0 luminescence of 4T1 NF-jB) ⁄ (Day 7 lumi-
nescence of 4T1 CMV tumor ⁄Day 0 luminescence of 4T1
CMV tumor).
Tumor-infiltrating lymphocyte isolation and flow cytome-
try. The 4T1 NF-jB cells were inoculated s.c. or i.f.p., and
7 days after inoculation tumor tissues were dissected, minced,
and digested with 2 mg ⁄mL collagenase (Roche Diagnostics,
Mannheim, Germany) and 0.1 mg ⁄mL DNase I (Roche Diag-
nostics) in serum-free RPMI-1640 for 1 h at 37°C. Samples
were further homogenized through wire mesh and mononuclear
cells were isolated by Percoll gradient (30%). For flow cytom-
etry analysis, mononuclear cells were first pre-incubated with
CD16 ⁄32 (2.4G2) mAb to avoid non-specific binding of anti-
bodies to FccR. The cells were then incubated with a saturat-
ing amount of fluorophore-conjugated mAb. Antibodies to
CD3e (2C11), NKp46 (29A1.4), CD4 (GK1.5), CD8 (2.43),
CD62L (MEL-14), CD44 (IM7), CD25 (PC61), CD11b (M1
⁄70), CD11c (N418), F4 ⁄80 (BM8.1), and CD206 (C068C2)
were purchased from Biolegend (San Diego, CA, USA), eBio-
science (San Diego, CA, USA) or Tombo Bioscience (San
Diego, CA, USA). Intracellular staining of Foxp3 was carried




Fig. 1. Effect of distinct tissue microenvironments on the metastatic
behavior of 4T1 breast cancer cells. 4T1 CMV cells were inoculated s.c.
(right back) or into mammary fat pad with syngenic BALB ⁄ c mice (105
cells). On day 14, the luminescence of primary tumor (a) or lung
metastasis (b) were quantified by the IVIS imaging system. Data are
presented as the mean  SEM. *P < 0.05 (c) 4T1 cells were inoculated
s.c. or i.f.p. and tumor samples were harvested 7 days after the tumor
inoculation. Paraffin-embedded tumor sections were subjected to H&E
staining and representative images are shown.
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science) according to the kit protocol. Briefly, cells were fixed
with the fixation ⁄permeabilization buffer, washed with permea-
bilization buffer, and incubated with APC-conjugated anti-
Foxp3 Ab. Flow cytometry analysis was carried out with a
FACS Canto (BD Biosciences, San Jose, CA, USA) and the
data were analyzed with FlowJo software (Tree Star, Ashland,
OR, USA).
Histological analysis. The 4T1 NF-jB cells were inoculated
s.c. or i.f.p. and then tumor samples were harvested 7 days
after tumor implantation. After the animals were killed, tumor
samples were immediately fixed with 4% paraformaldehyde
for 1–2 days. The tumor sample was then sliced sequentially
into sections 3–5 mm thick. Representative sections of the
tumor and adjacent tissue 2–3 mm thick were selected and
embedded in paraffin for routine histopathological analysis
with H&E staining.
Cytokine and chemokine protein array. The 4T1 NF-jB cells
were inoculated s.c. or i.f.p., and 7 days after inoculation
tumor tissues were dissected, minced, and digested with 2 mg
⁄mL collagenase (Roche Diagnostics) and 0.1 mg ⁄mL DNase I
(Roche Diagnostics) in serum-free RPMI-1640 for 1 h at
37°C. Samples were further homogenized through wire mesh
and cultured with complete RPMI-1640 medium for 24 h. The
cell-free culture supernatants were collected and stored at
80°C. The protein expression of inflammatory cytokines and
chemokines was measured by HQPLEX Analyte Kit (Mouse
Inflammation 17-Plex; Cellector, San Diego, CA, USA)
according to the manufacturer’s instructions and data were
analyzed using BeadLogic software (Inivai Technologies, Men-
tone, Australia).
Statistical analysis. All data were obtained from a group of
four or five mice and are representative of at least two inde-
pendent experiments. Data were analyzed for statistical signifi-
cance using Student’s t-test. P-values < 0.05 were considered
significant.
Results
Tissue microenvironment affects metastatic behavior of 4T1
tumors. It has been recognized that the surrounding tissue
microenvironment of the primary tumor collaborates with can-
cer cells for metastasizing to distant organs.(2,6) Murine 4T1
breast cancer cells are known to spontaneously metastasize to
multiple distant organs after in vivo inoculation either s.c.
(ectopic) or into mammary fat pad (orthotopic, i.f.p.).
Although 4T1 cells grew more slowly in the orthotopic mam-
mary fat pad tissue compared to s.c. tissue (Fig. 1a), the i.f.p.
4T1 tumor metastasized more efficiently to the lung than the
s.c. tumor (Fig. 1b). Interestingly, the tissue architecture of
i.f.p. 4T1 tumors and s.c. 4T1 tumors was significantly differ-
ent (Fig. 1c). While the s.c. 4T1 tumor mostly consisted of
cancer cells, the mammary fat-pad 4T1 tumor showed larger
tissue heterogeneity, with the involvement of adipocytes and
fibrotic lesions (Fig. 1c). These results imply that the mam-
mary fat pad tissue may positively influence 4T1 cancer cells
to metastasize to the lung to a greater degree than the s.c. tis-
sue.
Formation of inflammatory microenvironment in mammary
fat-pad but not s.c. 4T1 tumor. We next monitored the spatio-
temporal changes of luminescence from 4T1 NF-jB cells to
investigate the inflammatory status of 4T1 breast cancer cells
in a different tumor microenvironment. Considering the tissue
origin of 4T1 cells, we implanted 4T1 luciferase reporter cells
in the s.c. tissue either orthotopically (mammary fat-pad, i.f.p.)
or ectopically (right back, s.c.). Although both 4T1 CMV cells
and 4T1 NF-jB cells after s.c. inoculation showed linear
increase in the bioluminescence (Fig. 2a), 4T1 NF-jB cells
inoculated into mammary fat-pad showed a transient increase
in bioluminescence approximately 7 days after tumor inocula-
tion (Fig. 2b). Considering the behavior of the biolumines-
cence of i.f.p. inoculated 4T1 CMV cells was similar to that of
(a)
(b)
Fig. 2. Time-course bioluminescence imaging of
s.c. 4T1 tumor in mice. 4T1 CMV cells or 4T1 nuclear
factor-jB cells were inoculated s.c. (right back) (a)
or into mammary fat pad (b) with syngenic BALB ⁄ c
mice and the luminescence was monitored using
the IVIS imaging system. The tumor volume of 4T1
CMV cells and 4T1 NF-jB cells were similar (data
not shown). The images and time-course of
luminescence are shown. The data are presented as
the mean  SEM.
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s.c. inoculated 4T1 CMV cells, these results imply that NF-jB
activity in 4T1 cells was specifically induced within the mam-
mary fat-pad tissue microenvironment. As the status of NF-jB
activity in 4T1 cells is proportional to the bioluminescence of
4T1 NF-jB cells and should reflect the surrounding inflamma-
tory microenvironment, the microenvironment in mammary tis-
sue, but not in ectopic s.c. tissue, most likely determined the
inflammatory status of 4T1 breast cancer cells.
Requirement of host immune response for establishing inflam-
matory 4T1 tumor microenvironment in mammary fat-pad. To
determine the requirement of the host immune response for
establishing an inflammatory 4T1 tumor microenvironment in
the mammary fat-pad, we carried out bioluminescence imaging
of 4T1 NF-jB cells in the immune-deficient mice. To normal-
ize the inflammatory status to tumor growth rate in the differ-
ent immunological environments, the luciferase activity of 4T1
NF-jB cells relative to that of 4T1 CMV cells under different
conditions was calculated and represented as an inflammatory
induction index (NF-jB ⁄CMV) (Fig. 3). Induction of inflam-
mation was observed in i.f.p. 4T1 tumor, but not in s.c. 4T1
tumor (Fig. 3a); such induction was totally diminished in both
SCID mice (Fig. 3b) and nude mice (Fig. 3c) that are deficient
in both T and B cells, or T cells alone, respectively. These




Fig. 3. Requirement of host immune responses for
establishing inflammatory 4T1 tumor micro-
environment in mammary fat pad. 4T1 CMV cells or
4T1 nuclear factor-jB (NF-jB) cells were inoculated
s.c. or into mammary fat pad (i.f.p.) with wild-type
BALB ⁄ c (a), i.f.p. with SCID (b), or nude mice (c).
The images of luminescence on day 0 and 7 after
tumor inoculation are shown. The index of relative
induction of luminescence in either ectopic or
orthotopic 4T1 NF-jB was calculated and is shown
as a bar graph. All graphs are shown as a summary
of two independent experiments and presented as
the mean  SEM. Total animal numbers: (a) s.c.,
n = 8; fat pad, n = 10; (b) BALB ⁄ c, n = 8; SCID,
n = 10; (c) BALB ⁄ c, n = 9; nude, n = 10. *P < 0.05.
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(a)
(b)
Fig. 4. Tissue microenvironment as a determinant for T cell-dependent inflammation in 4T1 tumor. (a) 4T1 CMV cells or 4T1 nuclear factor-jB
(NF-jB) cells were inoculated into mammary fat pad (i.f.p.) in wild-type BALB ⁄ c mice. To deplete CD4+ or CD8+ T cells, mice were treated with
anti-CD4 antibody or anti-CD8 antibody (250 lg ⁄ mouse, i.p.) on day 2, 1, and 7. The images of luminescence on day 0 and 7 are shown. The
index of relative induction of luminescence in either control or antibody-treated mice was calculated. The graph is shown as a summary of two
independent experiments (total animal numbers: control, n = 10; anti-CD4, n = 10; anti-CD8, n = 9) and presented as the mean  SEM. (b) 4T1
NF-jB cells were inoculated s.c. or i.f.p. and tumor samples were harvested 7 days after tumor inoculation. Tumor-infiltrating lymphocytes were
isolated and subjected to flow cytometry analysis. The dot plots electronically gated on lymphocytes (left), CD4+ T cells (middle and right, CD4+
CD3+) are shown. *P < 0.05.
Fig. 5. T cell-dependent induction of
inflammatory mediators within mammary fat pad
4T1 tumor microenvironment. 4T1 nuclear factor-jB
cells were inoculated s.c. or into mammary fat pad
and tumor samples were harvested 7 days after
tumor inoculation. To deplete CD4+ or CD8+ T cells,
mice were treated with anti-CD4 antibody or anti-
CD8 antibody (250 lg ⁄ mouse, i.p.) on day 2 and
1. Tumor samples were harvested on day 7 and
cells were cultured for 24 h to collect the
supernatant. All graphs are presented as the mean
 SEM. *P < 0.05. IL, interleukin; MIP, macrophage
inflammatory protein; N.D., no data.
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dent host immune responses for establishing an inflammatory
4T1 tumor microenvironment.
Mammary tissue microenvironment as a determinant for T cell-
dependent inflammation in 4T1 tumor. Given that a T cell
requirement was indicated (Fig. 3), we then further determined
which subset of T cells is involved in establishing an inflam-
matory 4T1 tumor microenvironment within the mammary fat
pad. Using anti-CD4 mAb or anti-CD8 mAb depletion, we
observed a significant reduction of NF-jB activation in mam-
mary fat-pad 4T1 tumor in CD4-depleted mice (Fig. 4a).
Although CD8 depletion was not statistically significant
(P = 0.084), there was a substantial reduction of NF-jB acti-
vation in CD8-depleted mice (Fig. 4a). These results support
that predominantly CD4+ subsets of T cells were required for
the establishment of an inflammatory 4T1 tumor microenviron-
ment in vivo. To explain the tissue specificity of mammary
fat-pad for establishing an inflammatory 4T1 tumor microenvi-
ronment in the context of T cell immune responses, we then
compared i.f.p. 4T1 tumors and s.c. 4T1 tumors for the differ-
ences in the infiltration of T cells into the tumors. Contrary to
the apparent differences in the inflammatory status of 4T1
cells, as seen by imaging analysis, there were no differences in
either total infiltration of T cells, the population of effector
memory CD4+ T cells (CD44+ CD62L), or the population of
regulatory CD4+ T cells (Foxp3+ CD25+/) between i.f.p. and
s.c. 4T1 tumor-infiltrating lymphocytes (Fig. 4b). In addition
to the above cellular analysis of 4T1 tumor infiltrating T cells,
the spatial localization of T cells within the tumor tissue was
examined by immunohistochemistry, however, this did not
show any apparent difference (data not shown). These results
suggest that the presence of T cells within the 4T1 tumor
microenvironment was critical but not solely responsible for
establishing an inflammatory 4T1 tumor microenvironment in
mammary tissue.
To further explore the molecular mechanism that is respon-
sible for establishing an inflammatory 4T1 tumor microenvi-
ronment in mammary tissue collaborating with T cells, we
used the inflammatory cytokine ⁄ chemokine protein array to
determine the factors involved in such T cell-dependent
inflammation in mammary 4T1 tumor. Of 17 cytokines
⁄ chemokines measured, the expression level of interleukin-1
(IL-1) and macrophage inflammatory protein (MIP) were sig-
nificantly higher in the fat-pad 4T1 tumor compared to the
s.c. tumor (Fig. 5). Given T cell depletion diminished such
induction of both IL-1 and MIP expression within fat-pad
4T1 tumor, the upregulation of those inflammatory cytokines
and chemokine expression requires both mammary tissue
microenvironment and T cell-dependent immune responses. In
accordance with such higher expression of inflammatory
mediators, we also observed higher frequency of the tumor-
associated macrophage (TAM) population (CD11b+ F4 ⁄80+
cells) in fat-pad 4T1 tumor compared to s.c. tumor (Fig. 6)
Considering there were no differences in the cell surface phe-
notype of both fat-pad and s.c. TAMs (Fig. 6), the higher
expression of inflammatory mediators, IL-1 and MIP, and ⁄or
infiltration of TAMs likely correspond to more inflamed 4T1
breast tumor microenvironment within orthotopic mammary
tissue compared to ectopic s.c. tissue.
Discussion
Although the importance of the tissue microenvironment and
its inflammatory status have been recognized as an essential
component of tumor progression and metastasis,(8,9,11,14) the
spatiotemporal process for establishing tissue-dependent can-
cer-associated inflammation is not well understood. In the pres-
ent study, by establishing in vivo bioluminescence imaging of
the NF-jB status in 4T1 breast cancer cells as a sensor of
inflammation, we showed the requirement of the tissue micro-
Fig. 6. Distinct tissue infiltration of tumor-associated macrophages
into 4T1 tumor. 4T1 nuclear factor-jB cells were inoculated s.c. or into
mammary fat pad and tumor samples were harvested 7 days after
tumor inoculation. Tumor-infiltrating lymphocytes were isolated and
subjected to flow cytometry analysis. The dot plots electronically
gated on myeloid cells (top) or macrophages (middle, CD11b+ F4 ⁄ 80+)
are shown. The bar graphs are presented as the mean  SEM.
*P < 0.05.
© 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd
on behalf of Japanese Cancer Association.
Cancer Sci | July 2015 | vol. 106 | no. 7 | 872
Original Articles
BLI of breast cancer-associated inflammation www.wileyonlinelibrary.com/journal/cas
environment for establishing an inflammatory 4T1 tumor in
collaboration with T cell-dependent immune responses.
Our results strongly indicate that the mammary tissue micro-
environment can contribute to determining the inflammatory
status of 4T1 breast cancer cells collaborating with the host
immune system, particularly with CD4+ T cells (Figs 3,4).
Notably, it is also suggested from our results that the immune
response per se is not sufficient for establishing mature cancer-
associated inflammation, but rather a heterogeneous interaction
between immune cells, cancer cells, and tissue stromal cells
seems to be required. Even though the precise underlying
mechanism for establishing an inflammatory microenvironment
in mammary fat-pad 4T1 tumors is not clear, there have been
studies that suggest various players might be involved in
cancer-associated inflammation, such as TAMs or cancer-asso-
ciated fibroblasts, together with tumor-infiltrating lympho-
cytes.(4,6)
In the specific context of the breast cancer tissue microenvi-
ronment, much attention has been given to mammary adipo-
cytes for playing a key role in tumor progression.(19)
Accumulating experimental evidence has shown that obesity
increases the risk of cancer and adipocytes secrete high levels
of pro-inflammatory mediators called adipokines, including
monocyte chemo-attractant protein-1, TNF-a, IL-6, IL-8, and
leptin.(19–22) Such adipokines are known to induce inflamma-
tory signals in cancer cells, including NF-jB-mediated signals,
and to play an important role in cancer-associated inflamma-
tion.(19,23) Moreover, a recent study showed that adipocytes
were able to differentiate into fibroblast-like cells within the
tumor microenvironment and promote tumor progression and
fibrosis in a manner similar to cancer-associated fibroblasts.(24)
Other studies showed that adipocytes promoted tumor cell
growth, invasion, and metastasis through adipokines.(25–30) In
addition, tumor-promoting macrophage recruitment and angio-
genesis were also induced by tumor-associated adipocytes.(31)
Considering we observed upregulation of inflammatory media-
tors, such as IL-1 or MIP, and higher frequency of TAM popu-
lations in fat-pad 4T1 tumor compared to s.c. tumor (Fig. 6),
and greater tissue heterogeneity in the mammary fat pad, as
seen in the involvement of adipocytes and fibrotic lesions
(Fig. 1c), we speculate that a 4T1 tumor can be inflamed by
collaborating with the mammary tissue microenvironment and
T cell-dependent immune response to facilitate the malignant
behavior of 4T1 cells.
Regarding the physiological importance of the inflammatory
tumor microenvironment, many previous studies have implied
that pathological inflammation contributes to tumor progres-
sion and metastatic spread to distant organs.(11,32) For instance,
systemic inflammation induced by lipopolysaccharide injection
has been shown to promote cancer cell invasiveness and there-
fore increase lung metastasis in vivo.(33,34) In our present find-
ings, the luminescent signal from 4T1 CMV tumors seems to
transiently decrease approximately 5–7 days after i.f.p. but not
s.c. inoculation of 4T1 cells (Fig. 2). Considering the signal
from the 4T1 CMV tumor directly reflects the number of via-
ble cancer cells, it is possible that the inflammatory 4T1 tumor
microenvironment could be a result of endogenous protective
antitumor immune responses against 4T1 cancer cells.
Although further study is clearly required to elucidate the
details of the molecular mechanisms, our present findings pos-
tulate an important clue, that distinct tissue environments and
⁄or tissue architecture might have different impacts on immune
responses to cancer cells, facilitating the establishment of
tumor-promoting inflammation. Alternatively, it is possible that
the combination of tissue microenvironment and immune
response is required for inducing the inflammatory tumor
microenvironment. Nevertheless, further investigation is clearly
required to understand the exact determinant for establishing
the metastasis-prone inflammatory microenvironment.
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